These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 38094217)

  • 1. Exploring the relationship between
    Cabezas-Cruz A; Bermúdez-Humarán LG
    Comput Struct Biotechnol J; 2024 Dec; 23():1-9. PubMed ID: 38094217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microbiota dysbiosis in inflammatory bowel diseases: in silico investigation of the oxygen hypothesis.
    Henson MA; Phalak P
    BMC Syst Biol; 2017 Dec; 11(1):145. PubMed ID: 29282051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic Influences of Gut Microbiota Dysbiosis on Inflammatory Bowel Disease.
    Sultan S; El-Mowafy M; Elgaml A; Ahmed TAE; Hassan H; Mottawea W
    Front Physiol; 2021; 12():715506. PubMed ID: 34646151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unraveling the Impact of Gut and Oral Microbiome on Gut Health in Inflammatory Bowel Diseases.
    Elzayat H; Mesto G; Al-Marzooq F
    Nutrients; 2023 Jul; 15(15):. PubMed ID: 37571313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New Insights into the Role of Oral Microbiota Dysbiosis in the Pathogenesis of Inflammatory Bowel Disease.
    Qi Y; Wu HM; Yang Z; Zhou YF; Jin L; Yang MF; Wang FY
    Dig Dis Sci; 2022 Jan; 67(1):42-55. PubMed ID: 33527328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
    Stecher B
    Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut microbiota, inflammatory bowel disease and colorectal cancer.
    Quaglio AEV; Grillo TG; De Oliveira ECS; Di Stasi LC; Sassaki LY
    World J Gastroenterol; 2022 Aug; 28(30):4053-4060. PubMed ID: 36157114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Insights into the Pathogenesis of Inflammatory Bowel Diseases: Genetics and Microbiota].
    Marchukov D; Misselwitz B
    Ther Umsch; 2019 Jan; 75(5):273-279. PubMed ID: 30700240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current understanding of microbiota- and dietary-therapies for treating inflammatory bowel disease.
    Eom T; Kim YS; Choi CH; Sadowsky MJ; Unno T
    J Microbiol; 2018 Mar; 56(3):189-198. PubMed ID: 29492876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbiota as key factors in inflammatory bowel disease.
    White Z; Cabrera I; Kapustka I; Sano T
    Front Microbiol; 2023; 14():1155388. PubMed ID: 37901813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut microbiota in the pathogenesis of inflammatory bowel disease.
    Nishida A; Inoue R; Inatomi O; Bamba S; Naito Y; Andoh A
    Clin J Gastroenterol; 2018 Feb; 11(1):1-10. PubMed ID: 29285689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Gut Microbiota in Inflammatory Bowel Disease-Current State of the Art.
    Askari H; Shojaei-Zarghani S; Raeis-Abdollahi E; Jahromi HK; Abdullahi PR; Daliri K; Tajbakhsh A; Rahmati L; Safarpour AR
    Mini Rev Med Chem; 2023; 23(13):1376-1389. PubMed ID: 36111766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diet-Microbiota Interactions in Inflammatory Bowel Disease.
    Sugihara K; Kamada N
    Nutrients; 2021 May; 13(5):. PubMed ID: 34062869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic review: the association between the gut microbiota and medical therapies in inflammatory bowel disease.
    Radhakrishnan ST; Alexander JL; Mullish BH; Gallagher KI; Powell N; Hicks LC; Hart AL; Li JV; Marchesi JR; Williams HRT
    Aliment Pharmacol Ther; 2022 Jan; 55(1):26-48. PubMed ID: 34751954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut microbiota changes in inflammatory bowel diseases and ankylosing spondilytis.
    Cardoneanu A; Mihai C; Rezus E; Burlui A; Popa I; Cijevschi Prelipcean C
    J Gastrointestin Liver Dis; 2021 Mar; 30(1):46-54. PubMed ID: 33548121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary Patterns and Gut Microbiota Changes in Inflammatory Bowel Disease: Current Insights and Future Challenges.
    Yan J; Wang L; Gu Y; Hou H; Liu T; Ding Y; Cao H
    Nutrients; 2022 Sep; 14(19):. PubMed ID: 36235658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of gut microbiota-bile acids axis by probiotics in inflammatory bowel disease.
    Li L; Liu T; Gu Y; Wang X; Xie R; Sun Y; Wang B; Cao H
    Front Immunol; 2022; 13():974305. PubMed ID: 36211363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dismicrobism in inflammatory bowel disease and colorectal cancer: changes in response of colocytes.
    Tomasello G; Tralongo P; Damiani P; Sinagra E; Di Trapani B; Zeenny MN; Hussein IH; Jurjus A; Leone A
    World J Gastroenterol; 2014 Dec; 20(48):18121-30. PubMed ID: 25561781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-Inflammatory and Immunomodulatory Effects of Probiotics in Gut Inflammation: A Door to the Body.
    Cristofori F; Dargenio VN; Dargenio C; Miniello VL; Barone M; Francavilla R
    Front Immunol; 2021; 12():578386. PubMed ID: 33717063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Microbial Metabolites on Microbiota-Gut-Brain Axis in Inflammatory Bowel Disease.
    Banfi D; Moro E; Bosi A; Bistoletti M; Cerantola S; Crema F; Maggi F; Giron MC; Giaroni C; Baj A
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.